These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37499740)

  • 41. Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.
    Cheng SH; Liu JM; Liu QY; Luo DY; Liao BH; Li H; Wang KJ
    Int J Clin Exp Pathol; 2014; 7(9):5855-63. PubMed ID: 25337227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105.
    Wood LM; Pan ZK; Guirnalda P; Tsai P; Seavey M; Paterson Y
    Cancer Immunol Immunother; 2011 Jul; 60(7):931-42. PubMed ID: 21431419
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.
    Fonsatti E; Nicolay HJ; Altomonte M; Covre A; Maio M
    Cardiovasc Res; 2010 Apr; 86(1):12-9. PubMed ID: 19812043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.
    Benetti A; Berenzi A; Gambarotti M; Garrafa E; Gelati M; Dessy E; Portolani N; Piardi T; Giulini SM; Caruso A; Invernici G; Parati EA; Nicosia R; Alessandri G
    Cancer Res; 2008 Oct; 68(20):8626-34. PubMed ID: 18922939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.
    Fonsatti E; Altomonte M; Nicotra MR; Natali PG; Maio M
    Oncogene; 2003 Sep; 22(42):6557-63. PubMed ID: 14528280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.
    Yang L; Zou X; Zou J; Zhang G
    Med Sci Monit; 2021 May; 27():e930639. PubMed ID: 33963171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study.
    Shi CS; Kuo KL; Chen MS; Chow PM; Liu SH; Chang YW; Lin WC; Liao SM; Hsu CH; Hsu FS; Chang HC; Huang KH
    Cells; 2019 Nov; 8(11):. PubMed ID: 31752390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→︀AKT→︀GSK3β→︀AM signaling.
    Chen Y; Li C; Xie H; Fan Y; Yang Z; Ma J; He D; Li L
    Oncogene; 2017 May; 36(20):2879-2888. PubMed ID: 28114284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene therapy for renal cancer.
    Haviv YS; Curiel DT
    Contrib Nephrol; 2008; 159():135-150. PubMed ID: 18391590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metastatic renal cell carcinoma: many treatment options, one patient.
    Rini BI
    J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutations in renal cell carcinoma.
    D'Avella C; Abbosh P; Pal SK; Geynisman DM
    Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracellular Vesicles and Carried miRNAs in the Progression of Renal Cell Carcinoma.
    Grange C; Brossa A; Bussolati B
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of endoglin (CD105) in cervical cancer.
    Zijlmans HJ; Fleuren GJ; Hazelbag S; Sier CF; Dreef EJ; Kenter GG; Gorter A
    Br J Cancer; 2009 May; 100(10):1617-26. PubMed ID: 19352388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target.
    Li L; Zhong L; Tang C; Gan L; Mo T; Na J; He J; Huang Y
    Clin Transl Oncol; 2022 Aug; 24(8):1447-1458. PubMed ID: 35165838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endoglin (CD105): a marker of tumor vasculature and potential target for therapy.
    Dallas NA; Samuel S; Xia L; Fan F; Gray MJ; Lim SJ; Ellis LM
    Clin Cancer Res; 2008 Apr; 14(7):1931-7. PubMed ID: 18381930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
    Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
    World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current updates and future perspectives on the management of renal cell carcinoma.
    Singh D
    Life Sci; 2021 Jan; 264():118632. PubMed ID: 33115605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. c-Ski accelerates renal cancer progression by attenuating transforming growth factor β signaling.
    Taguchi L; Miyakuni K; Morishita Y; Morikawa T; Fukayama M; Miyazono K; Ehata S
    Cancer Sci; 2019 Jun; 110(6):2063-2074. PubMed ID: 30972853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.